Pfizer faces multi-year headwinds from loss of exclusivity and COVID franchise decline, but management highlights transformative M&A and pipeline optionality. Learn more on PFE stock here.

Pfizer Inc. (NYSE:PFE) is one of the best medical research stocks to buy according to hedge funds. Pfizer Inc. (NYSE:PFE) ...

Pfizer's long-acting GLP-1 weight loss candidate could set the stage for a stock rally.

Studies show that women who use a contraceptive injection known as Depo-Provera could increase their risk of benign brain tumours by as much as 500 per cent.

Pfizer Inc. (NYSE:PFE) is one of the best healthcare stocks under $50 to invest in. Pfizer Inc. (NYSE:PFE) announced on February 6 that the U.S.

Entera Bio Ltd. (NASDAQ: ENTX) ("Entera" or the "Company"), a leader in the development of oral peptide and protein replacement therapies, today announced that its Board of Directors has appointed ...

Pfizer is currently facing a lawsuit from over 1,000 women, stating that Pfizer was aware of the risk that Depo-Provera posed, pointing back to studies from 1983 that detailed the link between the ...

After months of discussion, President Donald Trump’s new direct-to-consumer pharmaceutical site, TrumpRx, officially launched ...

President Donald J. Trump announced the launch of TrumpRx, the direct-to-consumer drug website that features reduced prices ...

Drugs on TrumpRx will be listed from AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer, which are the first five manufacturers to reach most favored nation pricing deals with the Trump ...

Pfizer plans to use a higher dose of the drug in phase three trials, and Bourla said it will produce efficacy and ...

In 2025, Pfizer PFE upped its efforts to rebuild its pipeline through acquisitions. Pfizer invested around $9 billion in M&A ...